Production (Stage)
Cytophage Technologies Ltd.
CYTO.V
TSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -52.46% | -39.05% | -34.72% | -34.97% | 12,278.08% |
Total Receivables | -51.48% | -52.44% | 6.87% | -4.58% | 12.23% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -60.30% | 215.87% | 31.25% | -54.72% | 107.84% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 40.91% | -37.64% | -27.26% | -53.74% | -90.26% |
Total Current Assets | -49.57% | -40.13% | -30.59% | -33.86% | 106.35% |
|
|||||
Total Current Assets | -49.57% | -40.13% | -30.59% | -33.86% | 106.35% |
Net Property, Plant & Equipment | -7.99% | -10.80% | 5.86% | 24.26% | -2.21% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -23.35% | -24.47% | -14.96% | -17.26% | 56.68% |
|
|||||
Total Accounts Payable | 50.28% | -5.71% | -12.15% | -11.42% | -27.75% |
Total Accrued Expenses | -19.28% | 45.10% | -0.72% | -34.47% | -38.36% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 4.08% | -32.37% | 1.28% | -8.97% | -9.14% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 9.32% | -4.85% | -3.74% | -17.50% | -77.22% |
|
|||||
Total Current Liabilities | 9.32% | -4.85% | -3.74% | -17.50% | -77.22% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -4.41% | -3.71% | -2.45% | -4.53% | -5.02% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 0.27% | -4.10% | -2.90% | -9.46% | -56.92% |
|
|||||
Common Stock & APIC | 0.10% | -6.11% | 1.73% | -1.00% | 51.69% |
Retained Earnings | -4.48% | 3.00% | -5.79% | -4.22% | -19.41% |
Treasury Stock & Other | 0.10% | -14.07% | -0.93% | -1.29% | 40.05% |
Total Common Equity | -39.52% | -34.06% | -19.66% | -19.95% | 1,601.66% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -39.52% | -34.06% | -19.66% | -19.95% | 1,601.66% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -39.52% | -34.06% | -19.66% | -19.95% | 1,601.66% |
|